Robert J. Capon
Impact in
- Biotechnology top 0.02%
- Marine Sponges and Natural Products
- Pharmacology top 0.1%
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
Papers in
- Biotechnology 178
- Marine Sponges and Natural Products 170
- Pharmacology 156
- Microbial Natural Products and Biosynthesis 151
- Co-authors
- Zeinab G. KhalilErnest LaceyAngela A. SalimAndrew M. PiggottJennifer H. GillMark S. ButlerSylvia UrbanJohn K. MacLeod
- Journals
- Journal of Natural Products (74 papers)Australian Journal of Chemistry (51 papers)Organic Letters (22 papers)Marine Drugs (18 papers)Organic & Biomolecular Chemistry (18 papers)
- Partner nations
- AustraliaChinaUnited States
In The Last Decade
Robert J. Capon
359 papers receiving 9.0k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Biotechnology 3.3k
- Pharmacology 3.3k
- Toxicology 398
- Organic Chemistry 3.3k
- Cancer Research 919
Countries citing papers authored by Robert J. Capon
This map shows the geographic impact of Robert J. Capon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Capon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Capon more than expected).
Fields of papers citing papers by Robert J. Capon
This network shows the impact of papers produced by Robert J. Capon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Capon. The network helps show where Robert J. Capon may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert J. Capon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 3 | |
| 5 | Antibiotics in the clinical pipeline as of December 2022 Hit paper breakdown → | 2023 | 129 |
| 6 | 2022 | 3 | |
| 7 | 2022 | 4 | |
| 8 | 2021 | 10 | |
| 9 | 2021 | 14 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 25 | |
| 12 | 2021 | 13 | |
| 13 | 2020 | 15 | |
| 14 | 2019 | 2 | |
| 15 | 2019 | 26 | |
| 16 | 2019 | 29 | |
| 17 | 2018 | 38 | |
| 18 | 2018 | 8 | |
| 19 | 2016 | 35 | |
| 20 | Structure Elucidation of a New Bufadienolide Toxin From the Flowers of Bryophyllum-Tubiflorum Harv (Crassulacea) | 1985 | 3 |
About Robert J. Capon
Robert J. Capon is a scholar working on Biotechnology, Pharmacology, Organic Chemistry, Cancer Research and Aquatic Science, having authored 369 papers that have together received 9.2k indexed citations. Recurring topics across this work include Marine Sponges and Natural Products (170 papers), Microbial Natural Products and Biosynthesis (151 papers), Synthetic Organic Chemistry Methods (72 papers), Synthesis and Biological Activity (58 papers), Streptococcal Infections and Treatments (30 papers), Chemical synthesis and alkaloids (27 papers), Genomics and Phylogenetic Studies (22 papers) and Neonatal and Maternal Infections (22 papers). The work is most often cited by research in Biotechnology (3.3k citations), Pharmacology (3.3k citations), Toxicology (398 citations), Organic Chemistry (3.3k citations) and Cancer Research (919 citations). Robert J. Capon has collaborated with scholars based in Australia, China and United States. Frequent co-authors include Zeinab G. Khalil, Ernest Lacey, Angela A. Salim, Andrew M. Piggott, Jennifer H. Gill, Mark S. Butler, Sylvia Urban, John K. MacLeod, Ritesh Raju and Shaun Tennant. Their work appears in journals such as Journal of Natural Products, Australian Journal of Chemistry, Organic Letters, Marine Drugs and Organic & Biomolecular Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.